Literature DB >> 17493802

Epidemiology of colorectal liver metastases.

Donald C McMillan1, Colin S McArdle.   

Abstract

In summary, the natural history of patients presenting with synchronous liver metastases has been well documented. However, the epidemiology and natural history of patients presenting with metachronous disease is scant. It is clear, therefore, that the accurate detection of occult liver metastases at the time of presentation underpins further improvements in the selection of appropriate treatment for patients presenting with colorectal cancer. This will facilitate early referral for investigation and treatment of their liver metastases.

Entities:  

Mesh:

Year:  2007        PMID: 17493802     DOI: 10.1016/j.suronc.2007.04.008

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  51 in total

1.  Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.

Authors:  K A Paschos; D Canovas; N C Bird
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

2.  Nodule and eminence on frenulum labii superioris: diagnostic markers for metastatic colorectal cancer.

Authors:  Rui Cao; Li-ping Wang; Jia-dong Chi; Xiong-zhi Wu
Journal:  Chin J Integr Med       Date:  2014-06-21       Impact factor: 1.978

3.  Hispidulin prevents hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells.

Authors:  Jing Xie; Hui Gao; Jianjun Peng; Yantao Han; Xuehong Chen; Qixiao Jiang; Chunbo Wang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  APOBEC3G expression is correlated with poor prognosis in colon carcinoma patients with hepatic metastasis.

Authors:  Huanrong Lan; Ketao Jin; Meifu Gan; Shouxiang Wen; Tienan Bi; Shenkang Zhou; Naibiao Zhu; Lisong Teng; Wenjie Yu
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 5.  Radioembolization of hepatic tumors.

Authors:  Andrew Kennedy
Journal:  J Gastrointest Oncol       Date:  2014-06

Review 6.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

7.  The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience.

Authors:  Mechteld C de Jong; Ronald M van Dam; Monique Maas; Marc H A Bemelmans; Steven W M Olde Damink; Geerard L Beets; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2011-09-05       Impact factor: 3.647

8.  Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.

Authors:  M Cosimelli; R Golfieri; P P Cagol; L Carpanese; R Sciuto; C L Maini; R Mancini; I Sperduti; G Pizzi; M G Diodoro; M Perrone; E Giampalma; B Angelelli; F Fiore; S Lastoria; S Bacchetti; D Gasperini; O Geatti; F Izzo
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

9.  Prognostic value of β1 integrin expression in colorectal liver metastases.

Authors:  Nikolaos Vassos; Tilman Rau; Susanne Merkel; Fabian Feiersinger; Carol I Geppert; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

10.  Recurrence patterns after laparoscopic resection of colorectal liver metastases.

Authors:  Nicolas Tabchouri; Brice Gayet; Shinya Okumura; Gianfranco Donatelli; Marc Beaussier; Mostefa Bennamoun; Christophe Louvet; David Fuks
Journal:  Surg Endosc       Date:  2018-05-14       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.